Cardiovascular dysfunction in dogs associated with critical illnesses

Journal of the American Animal Hospital Association

Volumn 42, Issue 5, 2006, Pages 344-349

  Nelson, O Lynne ^a   Thompson, Pam A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 33947140159     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0420344     Document Type: Article

References (31)

1. Hamlin RL. Pathophysiology of the failing heart. In: Fox PR, Sisson D, Moise NS, eds. Textbook of Canine and Feline Cardiology. 2nd ed. Philadelphia: WB Saunders, 1999:205-215.
2. Colucci WS, Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: WB Saunders, 1997:394-420.
3. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002;26:842-847.
4. Liu H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol 1999;14:600-608.
5. Noutsias M, Pauschinger M, Poller WC, et al. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003;3:127-135.
6. Dhainault JF, Hayghebaert MF, Monsallier JF, et al. Coronary hemodynamics and myocardial metabolism of lactate, for fatty acids, glucose and ketones in patients with septic shock. Circulation 1987;75:553-541.
7. Court O, Kumar A, Parrillo JE. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 2002;6:500-508.
8. Krishnagopalan S, Kumar A, Parrillo JE. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002;8:376-388.
9. Bozza M, Satoskar AR, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999;189:341-346.
10. Parrillo JE, Burch C, Shelhamer JH, et al. A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985;76:1539-1553.
11. Granton JT, Goddard CM, Allard MF, et al. Leukocytes and decreased left ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med 1997;155:1977-1983.
12. Guest TM, Ramanathan AV, Tuteur PG, et al. Myocardial injury in critically ill patients, a frequently unrecognized complication. JAMA 1995;273:1945-1949.
13. Thomas WP. Two-dimensional, real-time echocardiography in the dog. Vet Radiol Ultrasound 1984;25:48-52.
14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
15. Bonagura JD, O'Grady MR, Herring DS. Echocardiography: principles of interpretation. Vet Clin North Am Small Anim Pract 1985;15:1177-1194.
16. Atkins CE, Synder PS. Systolic time intervals and their derivatives for evaluation of cardiac function. J Vet Intern Med 1992;6:55-63.
17. Kyriakidis M, Antonopoulos A, Georgiakodis F, et al. Systolic time intervals after phenylephrine administration for early stratification of patients after acute myocardial infarction. Am J Cardiol 1994;73: 6-10.
18. Schober KE, Fuentes VL. Effects of age, body weight, and heart rate on transmitral and pulmonary venous flow in clinically normal dogs. Am J Vet Res 2001;62:1447-1454.
19. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996;9:736-760.
20. Walley KR, Becker CJ, Hogan RA, et al. Progressive hypoxemia limits left ventricular oxygen consumption and contractility. Circ Res 1988;63:849-859.
21. Steenbergen C, Deleeuw G, Rich T, et al. Effects of acidosis and ischemia on contractility and intracellular pH of rat heart. Circ Res 1988;41:849-858.
22. Walley KR, Lewis TH, Wood LDH. Acute respiratory acidosis decreases left ventricular contractility but increases cardiac output in dogs. Circ Res 1990;67:628-635.
23. Teplinsky K, O'Toole M, Olman M, et al. Effect of lactic acidosis on canine hemodynamics and left ventricular function. Am Physiol 1990;258:h1193-h1199.
24. Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implication of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 1988;84:209-214.
25. Walley KR, Wood LDH. Ventricular dysfunction in critical illness. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. 2nd ed. New York: McGraw-Hill, 1998:303-322.
26. Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus association with raised anticardiolipin antibodies. Circulation 1990;82:369-375.
27. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004; 116:305-311.
28. Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-932.
29. Parker MM, McCarthy KE, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990;97:126-131.
30. Suffredijni AF, From RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-287.
31. Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. Annals Intern Med 1990; 112:492-498.